Pureos Bioventures

📍 Pfäffikon, CH
🏷️ vc
Visit Website ↗
Investment Thesis

Pureos Bioventures invests in biotech companies developing innovative therapeutics, with a focus on next-generation biological drugs and drug formats. They aim to impact patients’ lives by advancing treatments for severe diseases, particularly in oncology, fibrosis, rare neurological disorders, and inflammatory diseases.

Stage Focus
Preclinical to clinical-stage biotech companies

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Innovative therapeutics, next-generation biological drugs, antibody-drug conjugates (ADCs), gene therapies, and precision monoclonal antibodies

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
N/A

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required

Investment Team (28)